Objectives: NCCN recommends testing for BRCA based on personal and family history of cancer and known mutations. BRCA testing can have preventative implications with increased screening and risk-reducing surgery if a mutation is diagnosed. The objective of this study was to determine the number of ...
The purpose of this study is to determine the frequency of AMH testing to monitor ovarian reserve and utility in clinical decision making among patients with BRCA1/2 mutations. Methods BRCA1/2 mutation carriers were retrospectively identified from electronic medical records using ICD-10 codes, and ...
Ninety eight women were enrolled in the study and allocated to four groups based on molecular DNA testing: generally healthy patients without the BRCA1 mutation, patients with breast cancer but without the BRCA1 mutation, generally healthy patients with the BRCA1 mutation, and patients with both ...
The objective of this study was to explore patterns of BRCA testing for patients over the last decade at our institution. Methods: This is a retrospective cohort study at three satellite sites within one institution. Patients were identified by ICD-10 codes associated with hereditary disposition of...